Form 4: Third Harmonic Bio CFO Receives Stock Options and Restricted Stock Units

Third Harmonic Bio's Chief Financial Officer, Christopher M. Murphy, was granted stock options and restricted stock units as part of the company's annual equity refresh program.

Summary

• Christopher M. Murphy, the Chief Financial and Business Officer of Third Harmonic Bio, Inc., received stock options and restricted stock units.
• The stock options grant is for 140,000 shares with an exercise price of $6.
• The options vest over four years, with an initial 2.0833% vesting on February 15, 2025, and then 2.0833% monthly thereafter.
• Murphy also received 17,500 restricted stock units (RSUs).
• The RSUs vest over four years, with 1/4 vesting on February 15, 2026, and then 1/4 annually thereafter.
• Both the stock options and RSUs were approved by the board on December 17, 2024, with an effective grant date of January 15, 2025.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation event, which is generally positive for aligning management with shareholder interests. There are no indications of negative issues.

Positives

• The equity grants align the CFO's interests with the company's long-term performance.
• The vesting schedule encourages continued service and commitment from the CFO.
• The grants are part of a regular annual refresh program, indicating a consistent approach to executive compensation.

Industry Context

Equity grants are a common practice in the biotechnology industry to attract and retain key executives, aligning their interests with the company's long-term success.

Comparison to Industry Standards

• The vesting schedule of four years for both options and RSUs is standard practice in the biotech industry.
• Companies like Amgen, Gilead, and Biogen also use similar equity-based compensation plans for their executives.
• The specific amounts of options and RSUs granted are likely based on the CFO's role, experience, and the company's overall compensation strategy.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align management's interests with the company's performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, equity compensation, executive compensation, vesting, CFO, Third Harmonic Bio, THRD